Literature DB >> 18668637

Rapidly progressive dementia.

Michael D Geschwind1, Huidy Shu, Aissa Haman, James J Sejvar, Bruce L Miller.   

Abstract

In contrast with more common dementing conditions that typically develop over years, rapidly progressive dementias can develop subacutely over months, weeks, or even days and be quickly fatal. Because many rapidly progressive dementias are treatable, it is paramount to evaluate and diagnose these patients quickly. This review summarizes recent advances in the understanding of the major categories of RPD and outlines efficient approaches to the diagnosis of the various neurodegenerative, toxic-metabolic, infectious, autoimmune, neoplastic, and other conditions that may progress rapidly.

Entities:  

Mesh:

Year:  2008        PMID: 18668637      PMCID: PMC2647859          DOI: 10.1002/ana.21430

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  125 in total

1.  Viral infection and cognitive decline.

Authors:  Ruth F Itzhaki; Matthew A Wozniak
Journal:  J Am Geriatr Soc       Date:  2007-01       Impact factor: 5.562

2.  Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes.

Authors:  L Bataller; K A Kleopa; G F Wu; J E Rossi; M R Rosenfeld; J Dalmau
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-15       Impact factor: 10.154

3.  Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.

Authors:  Josep Dalmau; Erdem Tüzün; Hai-yan Wu; Jaime Masjuan; Jeffrey E Rossi; Alfredo Voloschin; Joachim M Baehring; Haruo Shimazaki; Reiji Koide; Dale King; Warren Mason; Lauren H Sansing; Marc A Dichter; Myrna R Rosenfeld; David R Lynch
Journal:  Ann Neurol       Date:  2007-01       Impact factor: 10.422

4.  Beyond viruses: clinical profiles and etiologies associated with encephalitis.

Authors:  C A Glaser; S Honarmand; L J Anderson; D P Schnurr; B Forghani; C K Cossen; F L Schuster; L J Christie; J H Tureen
Journal:  Clin Infect Dis       Date:  2006-11-08       Impact factor: 9.079

5.  The diagnostic utility of brain biopsy procedures in patients with rapidly deteriorating neurological conditions or dementia.

Authors:  S Andrew Josephson; Alexander M Papanastassiou; Mitchel S Berger; Nicholas M Barbaro; Michael W McDermott; Joan F Hilton; Bruce L Miller; Michael D Geschwind
Journal:  J Neurosurg       Date:  2007-01       Impact factor: 5.115

Review 6.  Autoimmune encephalopathies.

Authors:  Steven Vernino; Michael Geschwind; Bradley Boeve
Journal:  Neurologist       Date:  2007-05       Impact factor: 1.398

7.  Primary central nervous system vasculitis: analysis of 101 patients.

Authors:  Carlo Salvarani; Robert D Brown; Kenneth T Calamia; Teresa J H Christianson; Stephen D Weigand; Dylan V Miller; Caterina Giannini; James F Meschia; John Huston; Gene G Hunder
Journal:  Ann Neurol       Date:  2007-11       Impact factor: 10.422

Review 8.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Aissa Haman; Bruce L Miller
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

Review 9.  Limbic encephalitis and variants: classification, diagnosis and treatment.

Authors:  Erdem Tüzün; Josep Dalmau
Journal:  Neurologist       Date:  2007-09       Impact factor: 1.398

10.  Rabies encephalitis in malaria-endemic area, Malawi, Africa.

Authors:  Macpherson Mallewa; Anthony R Fooks; Daniel Banda; Patrick Chikungwa; Limangeni Mankhambo; Elizabeth Molyneux; Malcolm E Molyneux; Tom Solomon
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

View more
  114 in total

1.  Detection of anti-glutamate receptor ε2 and anti-N-methyl-D: -aspartate receptor antibodies in a patient with sporadic Creutzfeldt-Jakob disease.

Authors:  Koji Fujita; Tatsuhiko Yuasa; Yukitoshi Takahashi; Keiko Tanaka; Shuji Hashiguchi; Katsuhito Adachi; Yuishin Izumi; Ryuji Kaji
Journal:  J Neurol       Date:  2011-11-05       Impact factor: 4.849

2.  Premortem diagnosis of sporadic Creutzfeldt-Jakob disease aided by positron-emission tomography imaging.

Authors:  W-J Zhang; M B Westover; C J Keary
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-11       Impact factor: 3.825

3.  The Fallacy of Persistent Postoperative Cognitive Decline.

Authors:  Michael S Avidan; Alex S Evers
Journal:  Anesthesiology       Date:  2016-02       Impact factor: 7.892

Review 4.  Rapidly progressive dementias and the treatment of human prion diseases.

Authors:  Brian S Appleby; Constantine G Lyketsos
Journal:  Expert Opin Pharmacother       Date:  2010-11-23       Impact factor: 3.889

5.  A rapid turn of events: sudden physical and cognitive decline.

Authors:  Roy Yaari; Susy Favaro; Anna D Burke; Helle Brand; Adam S Fleisher; James D Seward; Jan Dougherty; Pierre N Tariot
Journal:  Prim Care Companion CNS Disord       Date:  2013-06-27

6.  Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease.

Authors:  Numthip Chitravas; Richard S Jung; Diane M Kofskey; Janis E Blevins; Pierluigi Gambetti; R John Leigh; Mark L Cohen
Journal:  Ann Neurol       Date:  2011-06-14       Impact factor: 10.422

Review 7.  The evaluation of rapidly progressive dementia.

Authors:  Michael Henry Rosenbloom; Alireza Atri
Journal:  Neurologist       Date:  2011-03       Impact factor: 1.398

Review 8.  Neuroimaging of rapidly progressive dementias, part 1: neurodegenerative etiologies.

Authors:  A J Degnan; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2013-02-22       Impact factor: 3.825

Review 9.  The use of cerebrospinal fluid and neuropathologic studies in neuropsychiatry practice and research.

Authors:  Kalyani Kansal; David J Irwin
Journal:  Psychiatr Clin North Am       Date:  2015-03-18

Review 10.  Clinical Presentation, Diagnosis and Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Older Adults: A Review of the Evidence and its Implications for Clinical Care.

Authors:  David W Goodman; Sara Mitchell; Lauren Rhodewalt; Craig B H Surman
Journal:  Drugs Aging       Date:  2016-01       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.